Ubisoft proposes closing RedLynx and cuts 70 jobs in Singapore
Ubisoft has proposed closing RedLynx in Finland, which could affect up to 52 jobs, while 70 roles are cut at Ubisoft Singapore.
At Ubisoft Singapore, 70 jobs are being cut. Ubisoft says the studio will remain part of its global production organization.
RedLynx is the studio behind the Trials series and was acquired by Ubisoft in 2011. The studio’s last major standalone release was Trials Rising in 2019.
What happened
Multiple reports say Ubisoft is reorganizing again and cutting 70 jobs at Ubisoft Singapore. The studio worked on Skull and Bones, which launched in early 2024 after a long development cycle. GamesIndustry.biz estimates Ubisoft Singapore’s headcount at around 280 employees, meaning 70 affected roles amount to roughly a quarter of the studio. Ubisoft has said Singapore remains important within its global production organization, suggesting the studio is not being closed but is being scaled back.
The same reporting says Ubisoft has proposed closing RedLynx. The Finnish studio, part of Ubisoft since 2011, is best known for the Trials series. According to the information cited, a closure would affect up to 52 positions, but the plan still has to go through a formal local consultation and negotiation process in Finland. So the sources are talking about a proposed closure, not a final decision.
The RedLynx reporting lines up with earlier information about the studio. IGN and GamesIndustry.biz both identify RedLynx as the maker of the Trials games and confirm Ubisoft’s 2011 acquisition. Eurogamer names Trials Rising from 2019 as the studio’s last major standalone release. Gamespot also reports that after that release, RedLynx mainly worked as a support studio and on mobile projects. That makes the current restructuring especially notable, given the studio’s clear franchise history and relatively limited recent standalone output.
Timeline
2011 — Ubisoft acquires RedLynx and adds the Finnish studio to its international network.
2019 — Trials Rising launches as RedLynx’s last major standalone release.
Early 2024 — Skull and Bones launches after a long development period, with Ubisoft Singapore as a key development partner.
14 October 2026 — Multiple reports say 70 roles are affected at Ubisoft Singapore and that Ubisoft has proposed closing RedLynx.
14 October 2026 — Ubisoft says Ubisoft Singapore remains important within its global production organization.
14 October 2026 — Reporting says up to 52 RedLynx positions could be affected, pending the Finnish consultation process.
14 October 2026 — GamesIndustry.biz estimates Ubisoft Singapore at around 280 employees, putting the scale of the cuts into perspective.
Background
RedLynx has a long history within Ubisoft. The studio built several Trials games and was acquired by Ubisoft in 2011. The reporting provided suggests that after Trials Rising in 2019, RedLynx mainly worked as a support studio and on mobile games. That means the studio is tied not only to a well-known racing franchise, but also to a broader role inside Ubisoft’s production network.
The proposed closure of RedLynx fits into a wider restructuring as Ubisoft re-evaluates studios and teams. The Finnish process matters here: the sources stress that a formal local consultation and negotiation process must happen before any final decision can be made. That also explains why some headlines already talk about a closure, while the reporting itself is more cautious and says it is still only a proposal.
Ubisoft Singapore is closely linked to Skull and Bones. The game launched in early 2024 after a long development period and was previously described by Ubisoft CEO Yves Guillemot as a "quadruple-A game." The current restructuring therefore affects both a studio with its own franchise history and a team that worked on one of Ubisoft’s most talked-about recent projects. According to the provided information, Singapore will remain part of the global production organization, highlighting the difference between a closure proposal in Finland and a downsizing in Singapore.